Trends in the Prevalence of Functional Limitations Among US Cancer Survivors, 1999-2018

Vishal R Patel; S M Qasim Hussaini; Anne H Blaes; Alicia K Morgans; Alex B Haynes; Adewole S Adamson; Arjun Gupta

doi:10.1001/jamaoncol.2023.1180

Trends in the Prevalence of Functional Limitations Among US Cancer Survivors, 1999-2018

JAMA Oncol. 2023 Jul 1;9(7):1001-1003. doi: 10.1001/jamaoncol.2023.1180.

Authors

Vishal R Patel¹, S M Qasim Hussaini², Anne H Blaes³, Alicia K Morgans⁴, Alex B Haynes¹, Adewole S Adamson¹, Arjun Gupta³

Affiliations

¹ Dell Medical School, The University of Texas at Austin.
² Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, Maryland.
³ Masonic Cancer Center, University of Minnesota, Minneapolis.
⁴ Dana-Farber Cancer Institute, Boston, Massachusetts.

No abstract available

Plain language summary

This cross-sectional study examines trends in the prevalence of functional limitation in cancer survivors using data from the National Health Interview Survey.

MeSH terms

Cancer Survivors*
Humans
Neoplasms* / epidemiology
Prevalence
Risk Factors
Survivors
United States / epidemiology